IO Biotech Announces Participation in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Nov 12, 2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that members of its senior management team will participate in the following upcoming investor conferences:
Read more at globenewswire.com
